NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for metoclopramide


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data Presented by Salix Pharmaceuticals at the American Association for the Study of Liver Diseases Annual Meeting Demonstrate Protective Effect and Durability of Rifaximin for Maintenance of Remission of Hepatic Encephalopathy (HE)
2009 NOV 16 ... monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) Tablets, METOZOLVTM ODT (metoclopramide HCl), PEPCID® (famotidine) for Oral Suspension, Oral Suspension DIURIL® ...
Subject: Hepatic Encephalopathy
Price: $3.00
*
New findings reported from Gazi University describe advances in vomiting
2009 OCT 13 ... conducted a study "To compare the administration of sub hypnotic dose of propofol with metoclopramide and placebo in prevention of postoperative nausea and vomiting (PONV) after middle ear ...
Subject: Vomiting
Price: $3.00
*
New schizophrenia data have been reported by researchers at University of Sao Paulo
2009 JUL 27 ... haloperidol, ziprasidone, risperidone, amisulpride, and clozapine (neuroleptic drugs); metoclopramide and SCH 23390 (dopamine antagonists without antipsychotic properties); and ketamine (a ...
Subject: Schizophrenia
Price: $3.00
*
Research from Johns Hopkins University, Medical Department has provided new data on headache and migraine
2009 JUL 6 ... in incidence of acute akathisia related to the rate of infusion in patients receiving metoclopramide for acute nausea, vomiting, or migraine headache in the emergency department (E.D). ...
Subject: Headache and Migraine
Price: $3.00
*
Research from Tohoku University in the area of anti-infectives published
2009 SEP 21 ... and other amine drugs (ciprofloxacin, moxifloxacin, garenoxacin, desipramine, and metoclopramide) to assess the contribution of specific human cytosolic sulfotransferases (SULTs) to the ...
Subject: Anti-Infectives
Price: $3.00
*
Research from University of Munster, Department of Neurology in the area of headache and migraine therapy published
2009 SEP 7 ... follow the concept of stratified treatment. Before intake of NSAID and triptans, oral metoclopramide or domperidone is recommended. In very severe attacks, intravenous acetylsalicylic acid ...
Subject: Headache and Migraine Therapy
Price: $3.00
*
Research from University of Utah yields new findings on pharmacy research
2009 AUG 25 ... months of age or younger. When stratified by age, histamine H-2-receptor antagonists and metoclopramide were the most common medications involved in exposures in children 12 months of age and ...
Subject: Pharmacy Research
Price: $3.00
*
Research on anesthesia reported by scientists at University of Texas
2009 SEP 7 ... consisted of a combination of ondansetron (4 mg), 0 dexamethasone (4 mg), and metoclopramide (10 mg) at the end Of surgery. Assessments included recovery times to eye opening, ...
Subject: Anesthesia
Price: $3.00
*
Salix Pharmaceuticals Announces Statistically Significant Results for Both the Primary and Key Secondary Analyses of Rifaximin
2009 NOV 16 ... Tablets, APRISO™ (mesalamine) extended-release capsules 0.375 g., METOZOLVTM ODT (metoclopramide HCl), PEPCID® (famotidine) for Oral Suspension, Oral Suspension DIURIL® ...
Subject: Diarrhea
Price: $3.00
*
Salix Pharmaceuticals Announces Statistically Significant Results for Both the Primary and Key Secondary Analyses of Rifaximin in the Treatment of Non-Constipation Irritable Bowel Syndrome in Two Phase 3 Trials Target 1 and Target 2
2009 SEP 28 ... Tablets, APRISO™ (mesalamine) extended-release capsules 0.375 g., METOZOLVTM ODT (metoclopramide HCl), PEPCID® (famotidine) for Oral Suspension, Oral Suspension DIURIL® ...
Subject: Salix Pharmaceuticals, Ltd.
Price: $3.00
*
Salix Pharmaceuticals Previews American College of Gastroenterology 2009 Annual Scientific Meeting
2009 NOV 16 ... monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) Tablets, METOZOLVTM ODT (metoclopramide HCl), PEPCID® (famotidine) for Oral Suspension, Oral Suspension DIURIL® ...
Subject: Ulcer
Price: $3.00
*
Salix Pharmaceuticals Reports 2Q2009 Results Updates Full Year Guidance
2009 AUG 24 ... Suppository (Hydrocortisone Acetate Rectal Suppositories) 30 mg. METOZOLV™ ODT (metoclopramide), crofelemer, budesonide foam and rifaximin for additional indications are under ...
Subject: Salix Pharmaceuticals
Price: $3.00
*
Salix Pharmaceuticals Reports 3Q2009 Results
2009 NOV 23 ... "On September 4 METOZOLV ODT, our orally disintegrating tablet formulation of metoclopramide, was granted marketing approval by the FDA. We believe METOZOLV ODT again demonstrates ...
Subject: Salix Pharmaceuticals, Ltd.
Price: $3.00
*
Salix Pharmaceuticals to Present at BMO Conference
2009 AUG 10 ... Suppository (Hydrocortisone Acetate Rectal Suppositories) 30 mg. METOZOLV™ ODT (metoclopramide), budesonide foam, crofelemer and rifaximin for additional indications are under ...
Subject: Salix Pharmaceuticals, Ltd.
Price: $3.00
*
Salix Pharmaceuticals to Present at Credit Suisse Conference
2009 NOV 16 ... APRISO™ (mesalamine) extended-release capsules 0.375 g., METOZOLV™ ODT (metoclopramide HCl), PEPCID® (famotidine) for Oral Suspension, Oral Suspension DIURIL® ...
Subject: Salix Pharmaceuticals, Ltd.
Price: $3.00
*
Salix Pharmaceuticals to Present at JMP Securities Conference
2009 OCT 12 ... APRISO™ (mesalamine) extended-release capsules 0.375 g., METOZOLV™ ODT (metoclopramide HCl), PEPCID® (famotidine) for Oral Suspension, Oral Suspension DIURIL® ...
Subject: Salix Pharmaceuticals, Ltd.
Price: $3.00
*
Salix Pharmaceuticals to Present at Thomas Weisel Partners Conference
2009 SEP 14 ... Suppository (Hydrocortisone Acetate Rectal Suppositories) 30 mg. METOZOLV™ ODT (metoclopramide), budesonide foam, crofelemer and rifaximin for additional indications are under ...
Subject: Salix Pharmaceuticals, Ltd.
Price: $3.00
*
Salix Receives FDA Marketing APPROVAL FOR Metozolv ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD
2009 SEP 21 ... and Drug Administration (FDA) has granted marketing approval for METOZOLV™ ODT (metoclopramide HCl) 5mg and 10mg orally disintegrating tablets. METOZOLV ODT is indicated for the ...
Subject: Obesity and Diabetes
Price: $3.00
*
Tranzyme Pharma Receives FDA Fast Track Status for Its Oral GI Prokinetic Drug Candidate TZP-102
2009 AUG 10 ... surgery or be idiopathic in nature. The only FDA approved drug for gastroparesis is metoclopramide, for which the FDA recently ordered a "black box" warning due to the risk of often ...
Subject: Tranzyme Pharma
Price: $3.00
*
Wilmington Pharmaceuticals Receives FDA Approval for Orally Disintegrating Metoclopramide Tablet
2009 SEP 21 ... and Drug Administration (FDA) has granted marketing approval for METOZOLV™ ODT (metoclopramide HCl), an orally disintegrating formulation of...
Subject: Pharmaceuticals
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login